SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-004630
Filing Date
2024-01-16
Accepted
2024-01-16 16:18:19
Documents
10
Period of Report
2024-01-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K krtx-20240116.htm   iXBRL 8-K 38807
  Complete submission text file 0000950170-24-004630.txt   148457

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krtx-20240116.xsd EX-101.SCH 23867
4 EXTRACTED XBRL INSTANCE DOCUMENT krtx-20240116_htm.xml XML 4519
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 24535373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)